Navigation Links
Journal of Cardiovascular Nursing Urges Policies and Prevention To Reduce Deaths from Venous Thromboembolism
Date:11/6/2009

PHILADELPHIA, Nov. 6 /PRNewswire/ -- In a newly-published special supplement, the Journal of Cardiovascular Nursing calls for new hospital policies to prevent and treat venous thromboembolism (VTE), a major cause of death and disability in hospitals throughout the world. Lippincott Williams & Wilkins (LWW) is publishing the supplement to bring attention to VTE, a disease that includes both the common medical condition of deep vein thrombosis and its most serious complication, pulmonary embolism, which accounts for 10% of hospital deaths annually.

LWW is part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

"VTE is a major but often unrecognized cause of morbidity and mortality in hospitalized patients," said Barbara Riegel, DNSc, RN, FAAN, Editor of the Journal of Cardiovascular Nursing and University of Pennsylvania School of Nursing Professor. "Articles in our supplement call for better adherence to current treatment guidelines and hospital-wide education to better prevent and treat deep vein thrombosis and pulmonary embolism."

The supplement provides critical analysis and recommendations on improving the prevention, diagnosis, and treatment of venous thromboembolism.

Articles, and their lead authors, include:

  • Venous Thromboembolism: Commentary on Prevention and Treatment, by Geno J. Merli, MD, FACP, FHM
  • Venous Thromboembolism: A Chronic Illness, by Carol M. Mason, ARNP, CLS, FAHA
  • Pharmacological and Nonpharmacological Interventions for Venous Thromboembolism, by Janet B. Long, MSN, ACNP, CLS, FAHA, FNLA
  • Venous Thromboembolism: What Is Preventing Achievement of Performance Measures and Consensus Guidelines? by Jane Nelson Worel, MS, APRN-BC, APNP

"Nurses in acute care settings, particularly those working in cardiology, play a critical role in recognizing VTE," said Riegel. "The supplement seeks to improve VTE awareness and education among our thousands of professional readers."

About the Journal of Cardiovascular Nursing

The Journal of Cardiovascular Nursing is the official journal of the Preventive Cardiovascular Nurses Association. It is one of the leading journals for advanced practice nurses in cardiovascular care, providing thorough coverage of timely topics and information that is extremely practical for daily, on-the-job use. Each issue addresses the physiologic, psychologic, and social needs of cardiovascular patients and their families in a variety of environments. For more information, go to www.jcnjournal.com.

About Lippincott Williams & Wilkins

Lippincott Williams & Wilkins (LWW) is a leading international publisher for healthcare professionals and students with nearly 300 periodicals and 1,500 books in more than 100 disciplines publishing under the LWW brand, as well as content-based sites and online corporate and customer services.

LWW is a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health and pharmacy. Major brands include traditional publishers of medical and drug reference tools and textbooks, such as Lippincott Williams & Wilkins and Facts & Comparisons(r); and electronic information providers, such as Ovid(r), UpToDate(r), Medi-Span(r), and ProVation(r) Medical.

Wolters Kluwer Health is part of Wolters Kluwer, a leading global information services and publishing company. The company provides products and services for professionals in the health, tax, accounting, corporate, financial services, legal, and regulatory sectors. Wolters Kluwer had 2008 annual revenues of EUR3.4 billion ($4.9 billion), employs approximately 20,000 people worldwide, and maintains operations in over 35 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Amsterdam, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Visit www.wolterskluwer.com for information about our market positions, customers, brands, and organization.

About the Preventive Cardiovascular Nurses Association

The Preventive Cardiovascular Nurses Association (PCNA) is the leading nursing organization dedicated to preventing cardiovascular disease through assessing risk, facilitating lifestyle changes, and guiding individuals to achieve treatment goals. PCNA is well established with 2,200 members seeing over 2,000,000 new patients per year. Members promote comprehensive CVD risk reduction strategies for all individuals and populations. PCNA seeks to impact health disparities through programs and educational tools. The mission of PCNA emphasizes the important role of nurses in the promotion of cardiac and vascular disease prevention. This is accomplished through the integration of public and professional education and advocacy.

Provided by Newswise, online resource for knowledge-based news at www.newswise.com

    Media Contacts:
    Natalie McGroarty
    Senior Marketing Manager
    Wolters Kluwer Health
    215-628-7759
    natalie.mcgroarty@wolterskluwer.com

    Robert Dekker
    Director of Communications
    Wolters Kluwer Health
    215-521-8928
    robert.dekker@wolterskluwer.com

SOURCE Wolters Kluwer Health: Lippincott Williams & Wilkins


'/>"/>
SOURCE Wolters Kluwer Health: Lippincott Williams & Wilkins
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. News briefs from the journal Chest, August 2007
2. The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
3. Elsevier launches new journal: Stem Cell Research
4. Elsevier announces new journal on inflammatory bowel diseases
5. National Osteoporosis Foundation Teams Up With Ladies Home Journal Magazine to Launch a 10-city Mall Walk Tour
6. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
7. Good Clinical Practice Journal Awards: Winners Announced
8. Maimonides Expands Circulation of Physicians Practice Journal to Staten Island Doctors
9. American Heart Association Surgical Supplement Journal Report: Appropriate Hospital Discharge System Can Prevent Future Cardiac Events
10. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
11. Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... 28, 2017 , ... Columbus OH. Dr. Justin Harper, Founder of Juvly Aesthetics ... in the country to sit on the 2017 National Advisory Board for Allergan’s Facial ... Dr. Harper helped propel the clinic from a small start-up to number 78 in ...
(Date:3/28/2017)... ... March 28, 2017 , ... AutismOne announced the Board ... of Integrative Medicine and available for application on Saturday, May 27, 2017, following ... in Colorado Springs. , Ed Arranga, president of AutismOne, stated: "Many of the ...
(Date:3/28/2017)... Square, PA (PRWEB) , ... March 28, 2017 , ... ... online and across a variety of business channels. , While many results are ... of any public relations program. , When it comes to measurement, firms should ...
(Date:3/28/2017)... Perry, GA (PRWEB) , ... March 28, 2017 , ... ... headquarters to Marshallville, Georgia, in early March. , The seed processing plant opened in ... the location since 2016. The new office allows opportunity for transition of Patten Seed ...
(Date:3/28/2017)... NY (PRWEB) , ... March 28, 2017 , ... Oily skin is a common and ... Advanced Dermatology has a lot to offer to the discussion of dealing with ... news is that there are many home remedies that can help remove the oily shine ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... Md. , March 27, 2017  ImMAGE Biotherapeutics ... its immunotherapy successfully passed early toxicology and efficacy studies. ... system to target a specific protein, MAGE A, in ... negative breast cancer. After 4 weeks ... able to show very little toxicity in a full ...
(Date:3/27/2017)... STUTTGART, Germany , March 27, 2017 /PRNewswire/ ... provide over 7,000 attendees and more than 600 ... learn, and discover opportunities and solutions that will ... - 6 April 2017 at the Messe Stuttgart, ... is the preeminent medical technology platform showcasing the ...
(Date:3/27/2017)... CHICAGO , March 27, 2017  A ... Educators (AADE) found that Medicare,s Competitive Bidding Program (CBP) ... diabetes testing supplies. The lack of choice forces beneficiaries ... can have dire health consequences. AADE,s ... reports by AADE and others pointing out the inherent ...
Breaking Medicine Technology: